{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:16:45Z","timestamp":1762507005896},"reference-count":56,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T00:00:00Z","timestamp":1484870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The increased risk of subsequent primary malignancies (<jats:styled-content style=\"fixed-case\">SPM<\/jats:styled-content>) in survivors of adult\u2010onset Hodgkin lymphoma (<jats:styled-content style=\"fixed-case\">HL<\/jats:styled-content>) and non\u2010Hodgkin lymphoma (<jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content>) remains a challenging clinical problem worldwide. The German cancer registry database, pooled from 14 federal states, was used to calculate the standardized incidence ratio (<jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>) and excess absolute risk (<jats:styled-content style=\"fixed-case\">EAR<\/jats:styled-content>) of <jats:styled-content style=\"fixed-case\">SPM<\/jats:styled-content> in 128\u00a0587 patients registered with first primary <jats:styled-content style=\"fixed-case\">HL<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content> between 1990 and 2012. Conversely, <jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>s were also calculated for a subsequent <jats:styled-content style=\"fixed-case\">HL<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content> following other first cancers. The risk of developing <jats:styled-content style=\"fixed-case\">SPM<\/jats:styled-content> was significantly increased over twofold for <jats:styled-content style=\"fixed-case\">HL<\/jats:styled-content> survivors (<jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>\u00a0=\u00a02\u00b714, <jats:styled-content style=\"fixed-case\">EAR<\/jats:styled-content>\u00a0=\u00a051\u00b787 cases\/10\u00a0000 person\u2010years) and 1\u00b75\u2010fold for <jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content> survivors (<jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>\u00a0=\u00a01\u00b748, <jats:styled-content style=\"fixed-case\">EAR<\/jats:styled-content>\u00a0=\u00a055\u00b723) compared with the general German population. For solid cancers, <jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>s were significantly elevated (1\u00b76\u2010 and 1\u00b74\u2010fold; respectively) and were highest (threefold) in patients below 30\u00a0years of age upon initial diagnosis. Overall, <jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>s were consistently elevated for lip\/oral cavity, colon\/rectum, lung, skin melanoma, breast, kidney and thyroid. Significantly increased <jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>s for oesophagus, stomach, liver, pancreas, testis, prostate, and brain\/central nervous system were observed following <jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content> only. For certain <jats:styled-content style=\"fixed-case\">SPM<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> SIR<\/jats:styled-content>s remained significantly elevated more than 10\u00a0years following <jats:styled-content style=\"fixed-case\">HL<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content> diagnosis. Positive reciprocal associations were demonstrated between <jats:styled-content style=\"fixed-case\">HL<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content> and several solid cancers mentioned above; for some, common aetiological mechanisms seem plausible.<\/jats:p>","DOI":"10.1111\/bjh.14530","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T21:34:31Z","timestamp":1484948071000},"page":"226-242","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Subsequent malignancies among long\u2010term survivors of Hodgkin lymphoma and non\u2010Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990\u20132012)"],"prefix":"10.1111","volume":"177","author":[{"given":"Nadia","family":"Baras","sequence":"first","affiliation":[{"name":"German Centre for Cancer Registry Data Robert Koch Institute Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Dahm","sequence":"additional","affiliation":[{"name":"German Centre for Cancer Registry Data Robert Koch Institute Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Haberland","sequence":"additional","affiliation":[{"name":"German Centre for Cancer Registry Data Robert Koch Institute Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Janz","sequence":"additional","affiliation":[{"name":"Haematology, Oncology and Tumour Immunology Charit\u00e9 \u2013 University Hospital Berlin, Campus Benjamin Franklin, and Max\u2010Delbrueck\u2010Centre for Molecular Medicine Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Emrich","sequence":"additional","affiliation":[{"name":"Cancer Registry Rhineland\u2010Palatinate gGmbH Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Kraywinkel","sequence":"additional","affiliation":[{"name":"German Centre for Cancer Registry Data Robert Koch Institute Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulgabar","family":"Salama","sequence":"additional","affiliation":[{"name":"Institute of Transfusion Medicine Charit\u00e9 \u2013 University Hospital Berlin, Campus Virchow Clinic Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,1,20]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf289"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6993.1491"},{"key":"e_1_2_9_4_1","first-page":"1","article-title":"Italian cancer figures, report 2013: multiple tumours (Abstract)","volume":"37","author":"AIRTUM Working Group","year":"2013","journal-title":"Epidemiologia E Prevenzione"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-1068"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70061-4"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.09.001"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602654"},{"key":"e_1_2_9_9_1","unstructured":"Breslow N.E.&Day N.E.(1987)Statistical methods in cancer research. Volume II\u2014the design and analysis of cohort studies.IARC Sci Publ Lyon82."},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.9174"},{"key":"e_1_2_9_11_1","volume-title":"New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973\u20132000 NIH Publ. No. 05\u20135302","author":"Curtis R.E.","year":"2006"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022473"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1998"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.038"},{"key":"e_1_2_9_15_1","first-page":"397","volume-title":"New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973\u20132000","author":"Dores G.M.","year":"2006"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-532184"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-512657"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.12.027"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.6068"},{"key":"e_1_2_9_21_1","unstructured":"Hentschel S.&Katalinic A.(eds.) (2008)Das Manual der epidemiologischen Krebsregistrierung (Manual of Population\u2010based Cancer Registration).Zuckschwerdt\u2010Verlag M\u00fcnchen."},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.02031.x"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.0936"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-013-1871-6"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2005.31013"},{"key":"e_1_2_9_26_1","unstructured":"IARC IACR & ENCR. (2004)International Rules for Multiple Primary Cancers (ICD\u2010O Third Edition).Lyon IARC. Available athttp:\/\/www.iacr.com.fr\/MPrules_july2004.pdf(Accessed 25 December 2014)."},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-94"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-009-1005-0"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00875-4"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.20.1530"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12684"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv018"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-497586"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0693"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.6832"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2014.34.e57"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgu013"},{"key":"e_1_2_9_38_1","first-page":"1481","article-title":"Risk of second cancer after treatment of aggressive non\u2010Hodgkin's lymphoma; an EORTC cohort study","volume":"91","author":"Moser E.C.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.2200"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0634"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09211.x"},{"key":"e_1_2_9_42_1","unstructured":"R Core Team. (2015)R: A Language and Environment for Statistical Computing.Vienna Austria:R Foundation for Statistical ComputingAvailable at:http:\/\/www.R-project.org\/."},{"key":"e_1_2_9_43_1","volume-title":"Cancer in Germany 2011\/2012","author":"Robert Koch Institute and the Association of population\u2010based Cancer Registries in Germany","year":"2015"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1007505"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25706"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12120"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70282-7"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197710)40:4 <1892::AID-CNCR2820400820>3.0.CO;2-H"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0b013e328355ed08"},{"key":"e_1_2_9_50_1","unstructured":"Swerdlow S.H. Campo E. Harris N.L. Jaffe E.S. Pileri S.A. Stein H. Thiele J.&Vardiman J.W.(ed.) (2008)WHO Classification of Tumours of Haematopoetic and Lymphoid Tissues.IARC Lyon."},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.8268"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.9777"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.3.182"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.4.465"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj001"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2013.41"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21971"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.14530","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.14530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T15:17:11Z","timestamp":1696346231000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.14530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,20]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1111\/bjh.14530"],"URL":"https:\/\/doi.org\/10.1111\/bjh.14530","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,20]]},"assertion":[{"value":"2016-07-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}